A Single Center, Open-label, Fixed Sequence, Two-period Study to Investigate the Effect of RO4917838 on the Pharmacokinetics of Rosuvastatin in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 10 Jun 2016
At a glance
- Drugs Bitopertin (Primary) ; Rosuvastatin
- Indications Atherosclerosis; Cardiovascular disorders; Hypercholesterolaemia; Hyperlipidaemia; Hypertriglyceridaemia; Schizophrenia
- Focus Pharmacokinetics
- Sponsors Roche
- 26 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported Roche record.
- 28 Aug 2010 New trial record